← All trials
NCT03252522
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 23, 2018
- Primary completion
- Jul 10, 2020
- Completion date
- May 31, 2021
- First posted
- Aug 17, 2017
- Last posted
- Feb 8, 2023
- Enrollment
- 135
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Oregon Health and Science UniversityLead sponsor
- National College of Natural MedicineCollaborator
- Ohio State UniversityCollaborator
- Oregon Health and Science UniversityOverall official - principal investigator
- Oregon Health and Science UniversityReponsible party - principal investigator
- University of LethbridgeCollaborator
- Waterloo FoundationCollaborator
- Oregon Health and Science UniversityOfficial
- Oregon Health and Science UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.